US2004105854A1PendingUtilityA1
Antibodies active against a fusion polypeptide comprising a histidine portion
Est. expiryMar 1, 2015(expired)· nominal 20-yr term from priority
C07K 16/1143C07K 16/32
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to an antibody active against a fusion polypeptide comprising a histidine portion, a process for the preparation thereof and its use.
Claims
exact text as granted — not AI-modified1 . An antibody against a fusion polypeptide comprising a histidine portion.
2 . The antibody according to claim 1 , characterized in that it is polyclonal.
3 . The antibody according to claim 1 , characterized in that it is monoclonal.
4 . The antibody according to claim 3 , characterized in that it is deposited under ACC 2207 with DSM [German-type culture collection for microorganisms].
5 . A process for the preparation of an antibody according to any one of claims 1 to 4 , characterized in that an animal is immunized with a histidine fusion polypeptide and
(a) polyclonal antibodies are obtained from the serum of the animal, or
(b) monoclonal antibodies are obtained after the fusion of animals spleen cells with myeloma cells.
6 . The process according to claim 5 , characterized in that a mixture of histidine fusion polypeptides is used for immunization.
7 . Use of an antibody according to any one of claims 1 to 4 in a detection method for a fusion polypeptide comprising a histidine portion.
8 . Use according to claim 7 , wherein the detection method is a Western blot, an ELISA, an immunofluorescence or an immunoprecipitation.Join the waitlist — get patent alerts
Track US2004105854A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.